Comparing effectiveness of high-dose Atorvastatin and Rosuvastatin among patients undergone Percutaneous Coronary Interventions: A non-concurrent cohort study in India

INTRODUCTION: Atorvastatin-80mg/day and Rosuvastatin-40mg/day are the commonest high-dose statin (3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors) regimes for post-PCI (Percutaneous Coronary Interventions) patients to lower (by ≥50%) blood low-density-lipoprotein cholesterol (LDL-C). Dear...

Descripción completa

Detalles Bibliográficos
Autores principales: Roy, Debabrata, Mahapatra, Tanmay, Manna, Kaushik, Kar, Ayan, Rana, Md Saiyed, Roy, Abhishek, Bose, Pallab Kumar, Banerjee, Barnali, Paul, Srutarshi, Chakraborty, Sandipta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237007/
https://www.ncbi.nlm.nih.gov/pubmed/32428019
http://dx.doi.org/10.1371/journal.pone.0233230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237007/
https://www.ncbi.nlm.nih.gov/pubmed/32428019
http://dx.doi.org/10.1371/journal.pone.0233230

Ejemplares similares